The generic name of Yamiro is tolizumab injection, which does not treat interstitial pneumonitis and is primarily used to treat rheumatoid arthritis and systemic juvenile idiopathic arthritis. The main ingredient of tozucizumab injection is tozucizumab, which is clinically used for adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to disease-improving antirheumatic medications; it is also used for the treatment of active systemic juvenile idiopathic arthritis in children 2 years of age or older who have had an inadequate response to prior treatment with nonsteroidal anti-inflammatory drugs and glucocorticosteroids. Tolizumab injection not only can not treat interstitial pneumonia, if used improperly, infection can occur, but also make liver enzymes rise, thrombocytopenia, gastrointestinal adverse reactions, internal organ disease, skin tissue disease, etc., before use should improve the examination, follow the doctor’s instructions for the use of drugs. It should be noted that the use of tolizumab injection is prohibited in patients with active infections and people who are allergic to the drug. If tozumab injection is needed for the treatment of the disease, you should go to a regular hospital, follow the doctor’s advice to use the drug regularly, regular review, adjustments at any time, to avoid irreversible damage.